COVID-19 patients have increased levels of membrane-associated and soluble CD48
H. Pahima, I. Zaffran, E. Ben-Chetrit, A. Jarjoui, P. Gaur, M. L. Manca, D. Reichmann, E. Orenbuch-Harroch, I. Puxeddu, C. Zinner, A. Tzankov, F. Levi-Schaffer
The paper finds increased levels of membrane-bound and soluble CD48 in COVID-19 patients through various assays, suggesting a potential therapeutic target.
bioRxiv · Mar 18, 2022 · PreprintImmunology